Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8+CD28- regulatory T lymphocytes by TCR crosslinking

PLoS Pathogens

Volumn 5, Issue 9, 2009, Pages

  Mertens, Janina ^a   Fabri, Mario ^a   Zingarelli, Alessandra ^a   Kubacki, Torsten ^a   Meemboor, Sonja ^a   Groneck, Laura ^a   Seeger, Jens ^a   Bessler, Martina ^a   Hafke, Helena ^a   Odenthal, Margarete ^a   Bieler, Joan G ^c   Kalka, Christoph ^b   Schneck, Jonathan P ^c   Kashkar, Hamid ^a   Kalka Moll, Wiltrud M ^a,d  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MVZ Dr Stein+Kollegen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; POLYSACCHARIDE; T LYMPHOCYTE RECEPTOR; CYTOKINE; INTERLEUKIN 10; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MOUSE; NONHUMAN; POPULATION; REGULATORY T LYMPHOCYTE; SEROTYPE; STREPTOCOCCUS PNEUMONIA; T LYMPHOCYTE ACTIVATION; ABDOMINAL ABSCESS; ANIMAL; ANTIGEN PRESENTING CELL; APOPTOSIS; BACTERIAL MEMBRANE; C57BL MOUSE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); MUS; STREPTOCOCCUS PNEUMONIAE;

ABDOMINAL ABSCESS; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; ANTIGENS, CD28; APOPTOSIS; BACTERIAL CAPSULES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 70349681968     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000596     Document Type: Article

References (82)

1. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL (1993) Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262: 416-419. (Pubitemid 23353382)
2. Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC, 3rd, Cywes C, et al. (1999) IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol 163: 893-897.
3. Tzianabos AO, Wang JY, Lee JC (2001) Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci U S A 98: 9365-9370.
4. Kalka-Moll WM, Wang Y, Comstock LE, Gonzalez SE, Tzianabos AO, et al. (2001) Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain. Infect Immun 69: 2339-2344. (Pubitemid 32239701)
5. Tzianabos AO, Chandraker A, Kalka-Moll W, Stingele F, Dong VM, et al. (2000) Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway. Infect Immun 68: 6650-6655. (Pubitemid 32463366)
6. Wang Y, Kalka-Moll WM, Roehrl MH, Kasper DL (2000) Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis. Proc Natl Acad Sci U S A 97: 13478-13483.
7. Choi YH, Roehrl MH, Kasper DL, Wang JY (2002) A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides. Biochemistry 41: 15144-15151.
8. Gallorini S, Berti F, Parente P, Baronio R, Aprea S, et al. (2007) Introduction of zwitterionic motifs into bacterial polysaccharides generates TLR2 agonists able to activate APCs. J Immunol 179: 8208-8215.
9. Kalka-Moll WM, Tzianabos AO, Bryant PW, Niemeyer M, Ploegh HL, et al. (2002) Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol 169: 6149-6153. (Pubitemid 36903459)
10. Stephen TL, Fabri M, Groneck L, Rohn TA, Hafke H, et al. (2007) Transport of Streptococcus pneumoniae capsular polysaccharide in MHC class II tubules. PLoS Pathog 3: e32. doi:10.1371/journal.ppat.0030032. (Pubitemid 46535807)
11. Cobb BA, Kasper DL (2008) Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology 18: 707-718.
12. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118. (Pubitemid 40977944)
13. Stephen TL, Niemeyer M, Tzianabos A, Kroenke M, Kasper D, et al. (2005) Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-cell stimulation. Infect Immun 73: 2184-2189. (Pubitemid 40470818)
14. Ruiz-Perez B, Chung DR, Sharpe AH, Yagita H, Kalka-Moll WM, et al. (2005) Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci U S A 102: 16753-16758. (Pubitemid 41688849)
15. Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620-625.
16. Stockinger B (1999) T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv Immunol 71: 229-265.
17. Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562. (Pubitemid 38680433)
18. Piccirillo CA, Shevach EM (2004) Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16: 81-88.
19. Mills KH (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855.
20. Aluvihare VR, Kallikourdis M, Betz AG (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5: 266-271. (Pubitemid 38332123)
21. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F (2005) Regulatory T cells and intestinal homeostasis. Immunol Rev 204: 184-194.
22. + regulatory T lymphocytes: the new era. Hum Immunol 69: 708-714.
23. Fenoglio D, Ferrera F, Fravega M, Balestra P, Battaglia F, et al. (2008) Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells. Hum Immunol 69: 745-750.
24. Endharti AT, Rifa IM, Shi Z, Fukuoka Y, Nakahara Y, et al. (2005) Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175: 7093-7097.
25. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H (2004) Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200: 1123-1134.
26. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, et al. (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268: 1472-1476.
27. Lee YH, Ishida Y, Rifa'i M, Shi Z, Isobe K, et al. (2008) Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol 180: 825-832.
28. Suzuki M, Konya C, Goronzy JJ, Weyand CM (2008) Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol 69: 781-789.
29. Jiang S, Tugulea S, Pennesi G, Liu Z, Mulder A, et al. (1998) Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum Immunol 59: 690-699. (Pubitemid 28467718)
30. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, et al. (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3: 237-243. (Pubitemid 34218114)
31. Filaci G, Suciu-Foca N (2002) CD8+ T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun Rev 1: 279-283.
32. Filaci G, Fenoglio D, Fravega M, Ansaldo G, Borgonovo G, et al. (2007) CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol 179: 4323-4334.
33. Xiao WB, Liu YL (2003) Changes of CD8+CD28- T regulatory cells in rat model of colitis induced by 2,4-dinitrofluorobenzene. World J Gastroenterol 9: 2528-2532.
34. Menager-Marcq I, Pomie C, Romagnoli P, van Meerwijk JP (2006) CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 131: 1775-1785. (Pubitemid 44970462)
35. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, et al. (2004) Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5: 516-523. (Pubitemid 38660464)
36. Li J, Goldstein I, Glickman-Nir E, Jiang H, Chess L (2001) Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J Immunol 167: 3800-3808. (Pubitemid 32910825)
37. Dhodapkar MV, Steinman RM (2002) Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100: 174-177.
38. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193: 233-238. (Pubitemid 32524454)
39. Gilliet M, Liu YJ (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195: 695-704. (Pubitemid 34259715)
40. Xystrakis E, Dejean AS, Bernard I, Druet P, Liblau R, et al. (2004) Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104: 3294-3301. (Pubitemid 39507148)
41. Janeway C, Travers P, Walport M, Shlomchik M (2005) Immunobiology. New York: Garland Science Publishing.
42. Groneck L, Schrama D, Fabri M, Stephen TL, Harms F, et al. (2009) Oligoclonal CD4+ T cells promote host memory immune responses to zwitterionic polysaccharide of Streptococcus pneumoniae. Infect Immun 77: 3705-3712.
43. Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, et al. (2009) Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457: 196-199.
44. Serbina NV, Flynn JL (2001) CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect Immun 69: 4320-4328. (Pubitemid 32574428)
45. + T-cell memory. Nat Rev Immunol 8: 107-119.
46. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, et al. (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232. (Pubitemid 47281420)
47. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24: 99-146.
48. Kashkar H, Kronke M, Jurgensmeier JM (2002) Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. Cell Death Differ 9: 750-757. (Pubitemid 34778042)
49. Perelson A (1984) Concepts and Models. In: Perelson A, Delisi C, Wiegel F, eds. Cell surface dynamics. New York: Marcel Dekker. pp 223-276.
50. Fahmy TM, Bieler JG, Edidin M, Schneck JP (2001) Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity 14: 135-143. (Pubitemid 32206516)
51. Lauffenburger DA, Linderman JJ (1993) Receptors: Models for Binding, Trafficking, and Signaling. New York: Oxford University Press. pp 133-180.
52. Najafian N, Chitnis T, Salama AD, Zhu B, Benou C, et al. (2003) Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 112: 1037-1048.
53. Farthmann EH, Schoffel U (1998) Epidemiology and pathophysiology of intraabdominal infections (IAI). Infection 26: 329-334.
54. Marshall JC, Innes M (2003) Intensive care unit management of intra-abdominal infection. Crit Care Med 31: 2228-2237. (Pubitemid 37011706)
55. Nichols RL (1985) Intraabdominal Infections: An Overview. Reviews of Infectious Diseases 7: S709-S715.
56. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712. (Pubitemid 129515761)
57. Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, et al. (2004) B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections]. J Immunol 172: 34-39. (Pubitemid 38020452)
58. Paust S, Lu L, McCarty N, Cantor H (2004) Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci US A 101: 10398-10403. (Pubitemid 38924937)
59. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265. (Pubitemid 46919862)
60. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB, et al. (2007) CD39 and control of cellular immune responses. Purinergic Signal 3: 171-180.
61. Rouleau M, Cottrez F, Bigler M, Antonenko S, Carballido JM, et al. (1999) IL-10 transgenic mice present a defect in T cell development reminiscent of SCID patients. J Immunol 163: 1420-1427. (Pubitemid 29352762)
62. Groux H, Cottrez F (2003) The complex role of interleukin-10 in autoimmunity. J Autoimmun 20: 281-285.
63. Wei S, Kryczek I, Zou L, Daniel B, Cheng P, et al. (2005) Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 65: 5020-5026. (Pubitemid 40827308)
64. Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, et al. (2004) Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 65: 142-156. (Pubitemid 38224140)
65. Filaci G, Rizzi M, Setti M, Fenoglio D, Fravega M, et al. (2005) Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci 1050: 115-123. (Pubitemid 41129428)
66. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A 89: 421-425.
67. Lider O, Santos LM, Lee CS, Higgins PJ, Weiner HL (1989) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142: 748-752. (Pubitemid 19093901)
68. Sugita S, Keino H, Futagami Y, Takase H, Mochizuki M, et al. (2006) B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest Ophthalmol Vis Sci 47: 5376-5384.
69. Sugita S, Ng TF, Lucas PJ, Gress RE, Streilein JW (2006) B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells. J Immunol 176: 118-127.
70. Hahn BH, Singh RP, La Cava A, Ebling FM (2005) Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors. J Immunol 175: 7728-7737. (Pubitemid 41713473)
71. Singh RP, La Cava A, Wong M, Ebling F, Hahn BH (2007) CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression. J Immunol 178: 7649-7657. (Pubitemid 46898035)
72. Singh RP, La Cava A, Hahn BH (2008) pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB6NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules. J Immunol 180: 2069-2080.
73. Schmitz ML, Krappmann D (2006) Controlling NF-kappaB activation in T cells by costimulatory receptors. Cell Death Differ 13: 834-842.
74. Strauss G, Knape I, Melzner I, Debatin KM (2003) Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. J Immunol 171: 1172-1182. (Pubitemid 36900045)
75. Fahmy TM, Bieler JG, Schneck JP (2002) Probing T cell membrane organization using dimeric MHC-Ig complexes. J Immunol Methods 268: 93-106.
76. Slansky JE, Rattis FM, Boyd LF, Fahmy T, Jaffee EM, et al. (2000) Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity 13: 529-538. (Pubitemid 30951876)
77. Daniels MA, Devine L, Miller JD, Moser JM, Lukacher AE, et al. (2001) CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15: 1051-1061. (Pubitemid 34075383)
78. Daniels MA, Hogquist KA, Jameson SC (2002) Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat Immunol 3: 903-910.
79. Fridkis-Hareli M, Reche PA, Reinherz EL (2004) Peptide variants of viral CTL epitopes mediate positive selection and emigration of Ag-specific thymocytes in vivo. J Immunol 173: 1140-1150. (Pubitemid 38924289)
80. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.
81. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92. (Pubitemid 29096240)
82. Dal Porto J, Johansen TE, Catipovic B, Parfiit DJ, Tuveson D, et al. (1993) A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci U S A 90: 6671-6675. (Pubitemid 23207275)